RUSHA vs RUSHB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
RUSHA exhibits strong operational health with a Piotroski F-Score of 7/9, indicating a robust financial foundation. However, the stock is significantly overvalued, trading at $73.93 despite a Graham Number of $46.02 and an Intrinsic Value of $22.89. While the company has an exceptional track record of beating earnings estimates over 25 quarters, current YoY revenue and earnings growth have turned negative (-11.8% and -11.0% respectively). The combination of a strong balance sheet and consistent execution is currently offset by expensive valuation metrics and bearish insider sentiment.
RUSHB exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9, indicating solid operational efficiency. However, the stock is severely overvalued, trading at $74.20—well above its Graham Number ($46.02) and Intrinsic Value ($22.89). This valuation gap is exacerbated by negative YoY revenue (-11.80%) and earnings growth (-11.00%), suggesting the current price is driven by momentum rather than fundamentals. Despite strong recent price performance, the combination of a high PEG ratio (3.09) and declining growth metrics points to a significant correction risk.
Compare Another Pair
Related Comparisons
RUSHA vs RUSHB: Head-to-Head Comparison
This page compares Rush Enterprises, Inc. (RUSHA) and Rush Enterprises, Inc. (RUSHB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.